These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 24168)

  • 21. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzylhydrazine--a selective inhibitor of human and rat brain monoamine oxidase.
    Roth JA
    Biochem Pharmacol; 1979 Mar; 28(6):729-32. PubMed ID: 454471
    [No Abstract]   [Full Text] [Related]  

  • 23. Selectivity of an indole-hydrazide derivative as inhibitor of mouse brain type A monoamine oxidase.
    Gurpegui M; Monge A; Fuentes JA
    Arzneimittelforschung; 1981; 31(10):1710-2. PubMed ID: 7198447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine oxidase inhibitors--current status.
    Zemishlany Z; Radwan M; Wijsenbeek H
    Isr J Psychiatry Relat Sci; 1983; 20(3):254-71. PubMed ID: 6325369
    [No Abstract]   [Full Text] [Related]  

  • 26. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some kinetic and inhibition properties of human brain mitochondrial monoamine oxidase (EC 1.4.3.4).
    Jain M; Bakutis E; Gayle T; Lansky P
    Neurobiology; 1974; 4(3):180-90. PubMed ID: 4367441
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzymology of monoamine oxidase.
    Tipton KF
    Cell Biochem Funct; 1986 Apr; 4(2):79-87. PubMed ID: 3518979
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes induced by ethanol in monoamine oxidase activity in the rat's brain mitochondria: MAO-DA and MAO-NA].
    Renis M; Giovine A; Bertolino A
    Acta Neurol (Napoli); 1974; 29(3):293-8. PubMed ID: 4422384
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of beta-fluorophenethylamine analogs on monoamine oxidase substrate preference.
    Meyerson LR; Fuller RW
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):581-4. PubMed ID: 30122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of tricyclic antidepressants upon human platelet monoamine oxidase.
    Edwards DJ; Burns MO
    Life Sci; 1974 Dec; 15(12):2045-58. PubMed ID: 4621003
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple forms of monoamine oxidase and their interaction with tricyclic psychomimetic drugs.
    Roth JA
    Gen Pharmacol; 1976 Dec; 7(6):381-6. PubMed ID: 65308
    [No Abstract]   [Full Text] [Related]  

  • 35. [Psychoactive drugs and their most recent developments].
    Ermili A
    Farmaco Prat; 1984 Aug; 39(8):267-90. PubMed ID: 6147270
    [No Abstract]   [Full Text] [Related]  

  • 36. Thyroidal biosynthesis of iodothyronines. II. General charactero acteristics and purification of mitochondrial monoamine oxidase.
    Fischer AG; Schulz AR; Oliner L
    Biochim Biophys Acta; 1968 Jul; 159(3):460-71. PubMed ID: 5657869
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of severe anxiety attacks with tricyclic antidepressants: a potential mechanism of action.
    Jobson K; Linnoila M; Gillam J; Sullivan JL
    Am J Psychiatry; 1978 Jul; 135(7):863-4. PubMed ID: 665806
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of hashish components and their mode of action on monoamine oxidase from the brain.
    Schurr A; Porath O; Krup M; Livne A
    Biochem Pharmacol; 1978; 27(21):2513-7. PubMed ID: 728206
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug interactions in the recovery room.
    Nagashima H
    Int Anesthesiol Clin; 1983; 21(1):93-105. PubMed ID: 6852944
    [No Abstract]   [Full Text] [Related]  

  • 40. [Opipramol in comparison to other drugs--new pharmacologic data].
    Müller WE; Siebert B
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S9-12. PubMed ID: 9922920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.